Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
News
9/3/2025
Aon Report Highlights Rapid Growth and Challenges in China's Health In...
9/3/2025
Ab&B Bio-Tech Gains Approval for First Quadrivalent Subunit Influenza ...
9/3/2025
China to Become World's Third-Largest Innovative Drug Market by 2028:...
9/3/2025
E-nitiate Biopharma Secures ~¥200M in Series B Funding to Advance Au...
9/3/2025
Sanofi China Receives Approval for Tzield to Delay Progression of Type...
9/3/2025
Argo Biopharma Strikes $5.2B Cardiovascular Collaboration with Novarti...
9/3/2025
China Biopharma Sees $320M Upfronts and $8.5B Milestones in H1 2025 Li...
9/3/2025
Global Pharma Firms Pour $48 Billion into China in H1 2025, IQVIA Repo...
9/2/2025
Astellas Accelerates Growth and Innovation in China
9/2/2025
Nine First-in-Class Drugs Receive Initial Clinical Approval in China
9/2/2025
Novatim and Radiance Forge Global Licensing Deal for Novel Cancer Ther...
9/2/2025
China Approved Seven New Drugs in August
9/1/2025
BioNTech Launches Phase 1/2 Trial of BNT327 and BNT3212 in Advanced Tu...
9/1/2025
Fosun Licenses Accro's TYK2/JAK1 Inhibitor AC-201 in Greater China
9/1/2025
Hongcheng Launches Phase II Trial for PD-1/CTLA-4/VEGF TsAb in Advance...
9/1/2025
Ennovabio Secures New Financing to Advance Pipeline for Immune and Met...
9/1/2025
Novel iPSC-Derived Neural Cell Therapy Shows Promise in SCI Treatment
9/1/2025
Convalife's HKEX IPO Application Gets Green Light
9/1/2025
Hengrui Seeks NMPA Approval for New Dual-Receptor Obesity Drug HRS9531
8/30/2025
Recent Executive Moves
8/30/2025
CMS Subsidiary Gets Approval to Launch Clinical Trials of Povorctinib
8/29/2025
Eli Lilly Partners with JD Health for Popular Weight-Loss Medicines
8/29/2025
Fosun Secures Exclusive Rights to ACCRO’s AC-201 in Greater China
8/29/2025
Adcoris Raises CNY Tens of Millions to Advance Next-Gen ADC Programs
8/29/2025
MagicRNA Raises ~CNY 100M in Pre-A+ Financing to Advance HN2301 Thera...
8/29/2025
D3 Bio's D3S-001 Receives FDA Breakthru Therapy and Orphan Drug Design...
8/29/2025
Boehringer's Zongertinib Gains Conditional Approval in China
8/29/2025
Hengrui's SHR2554 Receives Conditional NMPA Approval
8/29/2025
CDE Issues Draft Requirements for Module 2 Chemistry Doc...
8/29/2025
CDE Issues Technical Guideline for Non-Clinical Research of Vaccine Ad...
Page:
1
/
58
Total number of articles:
1711
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit